FdaApplication

NDA 021829

Back to search

Identifiers

Properties

PropertyValue
applicant_nameUCB INC
application_typeNDA
approval_date2007-05-09

Products (6)

ProductActive ingredientStrengthDosage form
NEUPROROTIGOTINE6MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
NEUPROROTIGOTINE2MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
NEUPROROTIGOTINE3MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
NEUPROROTIGOTINE1MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
NEUPROROTIGOTINE4MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
NEUPROROTIGOTINE8MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL

6 products